Improvement of Chronic Peyronie's Disease Symptoms After Diabetic Compensation: A Retrospective Study
Cavallini G, Paulis G. Urology. 2013 Feb 20. pii: S0090-4295(12)01575-0. doi: 10.1016/j.urology.2012.12.030. [Epub ahead of print]

Source

Medicitalia Andrological Section, Outpatient Clinic of Ferrara, 44121 Ferrara, Italy. Electronic address: giorgiocavallini@libero.it.

Abstract

OBJECTIVE:

To look for a link between compensation of diabetes in patients with uncompensated/undiagnosed diabetes with chronic Peyronie's disease (PD) and improvement of their PD symptoms.

METHODS:

Thirty-six nonsmoking patients with uncompensated diabetes and PD were studied. The plaque area and pain (ie, PD symptoms) were compared before and after a strict control of hemoglobin A1c and of glycemia at a timeframe of 37 ± 13 weeks. Thirty-two nonsmoking nondiabetic patients with PD who had their PD symptoms assessed twice with a mean time lag of 39 ± 11 weeks were used as controls. The differences in PD symptoms between the 2 assessments were evaluated using the Wilcoxon test. A Spearman rank correlation test was used to identify any correlation between glycemia before diabetic compensation and the percentage of decrease in the size of plaque of patients with diabetes.

RESULTS:

Plaque area and pain diminished in patients with diabetes, coincidentally with diabetes compensation and antidiabetic therapy administration. On the other hand, the controls had their plaque area significantly increased while their pain was not modified. The Spearman tests found a significant correlation between glycemia before diabetic compensation and the percentage of decrease in the size of plaque of patients with diabetes.

CONCLUSION:

Diabetes compensation and/or antidiabetic therapy improved PD symptoms.